Hamdy F - Search Results

1

PSA-detected prostate cancer and the potential for dedifferentiation--estimating the proportion capable of progression.

Pashayan N, Pharoah P, Neal DE, Hamdy F, Donovan J, Martin RM, Greenberg D, Duffy SW. Pashayan N, et al. Among authors: hamdy f. Int J Cancer. 2011 Mar 15;128(6):1462-70. doi: 10.1002/ijc.25471. Int J Cancer. 2011. PMID: 20499312 Clinical Trial.

2

Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult.

Donovan J, Mills N, Smith M, Brindle L, Jacoby A, Peters T, Frankel S, Neal D, Hamdy F. Donovan J, et al. Among authors: hamdy f. BMJ. 2002 Oct 5;325(7367):766-70. doi: 10.1136/bmj.325.7367.766. BMJ. 2002. PMID: 12364308 Free PMC article. Review.

3

Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.

Mills N, Donovan JL, Smith M, Jacoby A, Neal DE, Hamdy FC. Mills N, et al. Control Clin Trials. 2003 Jun;24(3):272-82. doi: 10.1016/s0197-2456(03)00020-5. Control Clin Trials. 2003. PMID: 12757993 Clinical Trial.

4

Early diagnosis and surgical management of prostate cancer.

Linton KD, Hamdy FC. Linton KD, et al. Cancer Treat Rev. 2003 Jun;29(3):151-60. doi: 10.1016/s0305-7372(03)00096-3. Cancer Treat Rev. 2003. PMID: 12787710 Review.

5

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.

Hamdy FC, Donovan JL, Lane JA, Neal DE. Hamdy FC, et al. BMJ. 2003 Jun 28;326(7404):1456. doi: 10.1136/bmj.326.7404.1456. BMJ. 2003. PMID: 12829565 Free PMC article. No abstract available.

6

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).

Donovan JL, Peters TJ, Noble S, Powell P, Gillatt D, Oliver SE, Lane JA, Neal DE, Hamdy FC; ProtecT Study Group. Donovan JL, et al. J Clin Epidemiol. 2003 Jul;56(7):605-9. doi: 10.1016/s0895-4356(03)00083-0. J Clin Epidemiol. 2003. PMID: 12921927 Clinical Trial.

7

Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study.

Oliver SE, Gunnell D, Donovan J, Peters TJ, Persad R, Gillatt D, Pearce A, Neal DE, Hamdy FC, Holly J. Oliver SE, et al. Int J Cancer. 2004 Mar 1;108(6):887-92. doi: 10.1002/ijc.11631. Int J Cancer. 2004. PMID: 14712493

8

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.

Oliver SE, Barrass B, Gunnell DJ, Donovan JL, Peters TJ, Persad RA, Gillatt D, Neal DE, Hamdy FC, Holly JM. Oliver SE, et al. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):163-5. doi: 10.1158/1055-9965.epi-03-0102. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14744750

9

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

Eaton CL, Wells JM, Holen I, Croucher PI, Hamdy FC. Eaton CL, et al. Prostate. 2004 May 15;59(3):304-10. doi: 10.1002/pros.20016. Prostate. 2004. PMID: 15042606

10

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.

Oliver SE, Holly J, Peters TJ, Donovan J, Persad R, Gillatt D, Pearce A, Hamdy FC, Neal DE, Gunnell D. Oliver SE, et al. Urology. 2004 Aug;64(2):317-22. doi: 10.1016/j.urology.2004.03.018. Urology. 2004. PMID: 15302487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

585 results

Search Page

Filters